rheumatology
Rare diseases

Sulfasalazine shows promise as a potential treatment for IgA-vasculitis

Sulfasalazine is a potential treatment for IgA-vasculitis (Henoch-Schönlein Purpura), according to Russian researchers who tested the drug in a small trial and found that most patients experienced complete remission of arthritis and skin rash. Dr Sergei Giliaev and colleagues from the First Moscow State Medical University decided to investigate sulfasalazine in patients with IgA-vasculitis because ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic